Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders

By Islam Md Serajul   Anoop Parameswaran   Gordon-Smith Edward C.   Rice Phil   Datta-Nemdharry Preeti   Marsh Judith C. W.  

Hematology, Vol. 15, Iss. 5, 2010-10 ,pp. : 344-350

Maney Publishing

Access to resources Recommend Favorite

Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts

By Slavin S.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3371-3373

Elsevier

Access to resources Recommend Favorite

Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease

By Hogan William   Storb Rainer  

Immunologic Research, Vol. 28, Iss. 1, 2003-08 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Non-HLA Gene Polymorphisms and the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 2, 2006-05 ,pp. : 239-253

Bentham Science Publishers

Access to resources Recommend Favorite

Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders

By Boulassel M. R.   Herr A. L.   Deb Edwardes M. D.   Galal A.   Lachance S.   Laneuville P.   Routy J. P.  

Hematology, Vol. 11, Iss. 3, 2006-06 ,pp. : 165-170

Maney Publishing

Access to resources Recommend Favorite